Related Experiment Video
Updated: Nov 17, 2025
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
[Rapid Cancer Fluorescence Imaging by Activatable Fluorescent Probes]
1Graduate School of Pharmaceutical Sciences, The University of Tokyo.
Abstract:
In this paper, novel rapid cancer imaging techniques using activatable fluorescent probes are showcased, whose fluorescence characteristics are significantly altered to distinguish between cancer sites, which was developed by using unique probe precision design methods established by the authors. The strategy is to develop probes that target enzymes whose activity has been reported to be enhanced in cancer sites, or to find the most suitable probes from a group of developed probes by screening using actual clinical specimens. Several medical technologies have been developed that enable selective detection of cancer sites within minutes by simply spraying the probes on suspected cancer sites. In addition, it has recently become clear that simultaneous imaging of multiple target enzyme activities can not only visualize the lesion site but also distinguish between malignant and benign lesions. It is highly expected that the day will soon come when surgeons will be able to clearly determine the cancer site to be treated and perform precise endoscopic or open-stomach surgery.
Insights
Novel activatable fluorescent probes enable rapid, precise cancer imaging by targeting cancer-specific enzymes. This technology allows surgeons to quickly distinguish and locate cancerous lesions for improved surgical outcomes.
Area of Science:
- Biomedical Engineering
- Medical Imaging
- Oncology
Background:
- Cancer detection often relies on invasive or time-consuming methods.
- There is a need for rapid and accurate imaging techniques to guide surgical interventions.
- Enzyme activity is known to be altered in cancerous tissues.
Purpose of the Study:
- To showcase novel rapid cancer imaging techniques using activatable fluorescent probes.
- To develop probes that target enzymes with enhanced activity in cancer sites.
- To enable precise visualization and differentiation of cancerous lesions.
Main Methods:
- Development of activatable fluorescent probes with unique precision design.
- Targeting enzymes with reported enhanced activity in cancer sites.
- Screening of probes using clinical specimens for optimal performance.
- Application of probes via spraying for rapid in-situ visualization.
Main Results:
- Fluorescence characteristics of probes are significantly altered to distinguish cancer sites.
- Selective detection of cancer sites within minutes is achieved.
- Simultaneous imaging of multiple enzyme activities allows differentiation between malignant and benign lesions.
Conclusions:
- Activatable fluorescent probes offer a rapid and precise method for cancer imaging.
- This technology has the potential to significantly improve surgical precision and patient outcomes.
- Future applications include enhanced intraoperative guidance for oncological surgery.
